2018-11-12T06:35:45-06:00 2018-06-30 251408703 SCHNEIDER DOWNS & CO INC ONE PPG PLACE SUITE 1700 PITTSBURGH PA 15222 990 2017-07-01 251562715 BLOOD SCIENCE FOUNDATION BLOO 4122097192 875 GREENTREE ROAD PARKWAY CENTER 5 PITTSBURGH PA 15220 MARK J GIAQUINTO PRESIDENT & CFO 4122097302 2018-11-05 1 EUGENE J LOGAN P00227231 4122613644 208.79.164.82 2018-11-05 09:46:43 ES P 2F809E41636C648B3B69A00E7F169955362743DB 2F809E41636C648B3B69A00E7F169955362743DB 2017 2019-02-21 02:37:17Z MARK J GIAQUINTO 875 GREENTREE ROAD PARKWAY CENTER 5 PITTSBURGH PA 15220 35996179 0 X HTTP://WWW.BLOODSCIENCEFOUNDATION.ORG X 1987 PA THROUGH PHILANTHROPY AND GRANT MAKING, THE BLOOD SCIENCE FOUNDATION SUPPORTS BLOOD SYSTEMS, INC. IN FULFILILNG THEIR MISSION TO ADVANCE CUTTING EDGE RESEARCH, PROVIDE A SAFE AND AMPLE BLOOD SUPPLY AND MEET THE NEEDS OF THE HEALTHCARE COMMUNITIES, PATIENTS AND DONORS OF PENNSYLVANIA, ILLINOIS AND VIRGINIA. 11 9 0 0 0 0 38918 218567 0 0 13782458 6296875 0 -6472 13821376 6508970 1672636 5686318 0 0 0 0 0 134801 469877 1218730 816333 2891366 6637452 10930010 -128482 54346455 51271547 924039 934324 53422416 50337223 THROUGH PHILANTHROPY AND GRANT MAKING, BSF SUPPORTS BSI IN FULFILILNG THEIR MISSION TO ADVANCE CUTTING EDGE RESEARCH, PROVIDE A SAFE AND AMPLE BLOOD SUPPLY AND MEET THE NEEDS OF THE HEALTHCARE COMMUNITIES, PATIENTS AND DONORS OF PA, IL AND VA. 0 0 5686318 5686318 BLOOD SCIENCE FOUNDATION (BSF) PROVIDES FUNDING DIRECTLY TO BLOOD SYSTEMS INC. TO SUPPORT THE MISSION OF THE ORGANIZATION, IN AN AMOUNT EQUALING OR EXCEEDING THE DISTRIBTUABLE AMOUNT AS DESCRIBED IN TREASURY REGULATION 1.509(A)-4(I)(5)(II). 5686318 1 1 0 0 0 0 0 0 0 1 0 1 0 1 0 1 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 8 0 1 0 0 0 0 0 0 1 1 0 0 0 0 X 11 9 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 PA OH WV VA X MARK J GIAQUINTO 4122097302 875 GREENTREE ROAD PARKWAY CENTER PITTSBURGH PA 15220 CHARLES BRACKEN DIRECTOR 1.00 0.00 X 0 0 0 SUNNY CHICO DIRECTOR 1.00 0.00 X 0 0 0 JAMES COVERT DIRECTOR 1.00 0.00 X 0 1820449 24185 PIERRE NOEL MD DIRECTOR (EXITED 3/18) 1.00 0.00 X 0 0 0 ROBERT OSTROWSKI DIRECTOR 1.00 0.00 X 0 0 0 ROGER OXENDALE DIRECTOR (ENTERED 9/17) 1.00 0.00 X 0 0 0 DAVID PEREZ DIRECTOR (ENTERED 9/17) 1.00 0.00 X 0 0 0 PATTY MASTANDREA DIRECTOR (ENTERED 1/18) 1.00 0.00 X 0 0 0 JIM SCHRAITH DIRECTOR (ENTERED 3/18) 1.00 0.00 X 0 0 0 MATTHEW SUHEY DIRECTOR 1.00 0.00 X 0 0 0 DONALD J MCGRAW MD CHAIR 1.00 0.00 X X 0 0 0 MARK GIAQUINTO PRESIDENT & CFO 40.00 0.00 X X 0 396513 32606 SHELLEY N BRANDT SECRETARY 40.00 0.00 X 0 81510 21903 0 2298472 78694 0 0 1 0 CAMPBELL & COMPANY 1 E UPPER WACKER DR STE 2100 CHICAGO IL 60601 FUNDRAISING MANAGEMENT 238328 1 26553 192014 218567 701088 701088 35067652 29471865 5595787 5595787 5595787 8872 26553 15344 -6472 -6472 6508970 0 0 6290403 5686318 5686318 522037 244551 277486 50086 47241 2845 134801 134801 32803 32803 124137 92571 31566 24514 24514 13533 12549 984 26759 17021 9738 7100 7100 DEVELOPMENT EXPENSE 1642 1642 13722 1265 12457 6637452 5686318 481257 469877 99963 266348 116515 4000 29365 4728 4789 35679114 34111868 8910135 10327177 9532000 6532000 54346455 51271547 924039 934324 924039 934324 X 53396966 50334648 25450 2575 53422416 50337223 54346455 51271547 -128482 -2956711 0 X 0 1 X 0 0 X X 1 BLOOD SYSTEMS INC 860098929 10 1 2686318 3951134 1 2686318 3951134 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 194866 8396 0 0 1222480 701088 1417346 709484 0 0 53628 0 0 0 1363718 709484 77763139 46146136 157553 610516 0 0 77920692 46756652 0 0 0 77920692 46756652 1168810 701349 76751882 46055303 2686316 1611936 0 0 2686316 1611936 1363718 1159160 2686316 2686316 0 2686316 2686316 0 0 0 0 0 2686316 2686316 2686316 100.000000000000 2686316 0 0 0 0 0 0 0 0 0 2686316 0 2686316 0 0 0 0 0 0 0 0 0 PART IV SECTION D LINE 3 BY REASON OF BSF'S RELATIONSHIP WITH BSI, THE SUPPORTED ORGANIZATION, BSI WILL HAVE A SIGNIFICANT VOICE IN THE INVESTMENT POLICIES OF BSF, THE TIMING OF GRANTS, THE MANNER OF MAKING GRANTS AND THE SELECTION OF RECIPIENTS (ALL GRANTS WILL GO TO BSI), AND OTHERWISE DIRECTING THE USE OF THE INCOME AND ASSETS OF BSF. 2560 15 2575 0.00000 0.00000 1.00000 0 0 0 ALTERNATIVE INVESTMENTS 10327177 C 10327177 ADVANCE TO RELATED PARTY 6532000 6532000 X 3560275 -2956711 40819 -2915892 6476167 32803 32803 6508970 6645468 40819 40819 6604649 32803 32803 6637452 PART V, LINE 4: BLOOD SCIENCE FOUNDATION ENDOWMENT WAS FORMED FOR VIRGINIA BLOOD SERVICES PART X, LINE 2: THE FOUNDATION IS AN ORGANIZATION AS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, AND FURTHER, IS CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION. SPECIFICALLY, THE FOUNDATION IS CLASSIFIED AS A TYPE III SUPPORTING ORGANIZATION UNDER SECTION 509(A)(3) OF THE INTERNAL REVENUE CODE. THEREFORE, NO PROVISION FOR INCOME TAXES HAS BEEN MADE FOR THIS ENTITY. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY TAX AUTHORITIES IN ANY MAJOR TAX JURISDICTION BEFORE 2015. THE FOUNDATION FOLLOWS THE CODIFICATION TOPIC ON INCOME TAXES, WHICH PRESCRIBES A MINIMUM RECOGNITION THRESHOLD AND MEASUREMENT METHODOLOGY THAT A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN IS REQUIRED TO MEET BEFORE BEING RECOGNIZED IN THE FINANCIAL STATEMENTS. THE FOUNDATION'S BALANCE SHEET DOES NOT INCLUDE ANY LIABILITIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS; FURTHER, THE FOUNDATION HAS NO UNRECOGNIZED TAX BENEFITS. PART XI, LINE 2D - OTHER ADJUSTMENTS: INKIND RENTAL 40,819. PART XII, LINE 2D - OTHER ADJUSTMENTS: INKIND RENTAL 40,819. X X X X 1 CAMPBELL & COMPANY 1 E UPPER WACKER DR STE 2100 CHICAGO IL 60601 INTERIM FUNDRAISING MANAGEMENT 0 0 134801 -134801 134801 -134801 PA OH WV VA TASTE THE GOOD LIFE EVENT 35425 26553 8872 4250 11094 35425 26553 8872 4250 11094 15344 -6472 SCHEDULE G, PART I, LINE 2B, COLUMN (V) IN RETAINING CAMPBELL AND COMPANY'S SERVICES, BSF RECEIVED INTERIM FUNDRAISING MANAGEMENT SERVICES THAT INCLUDED STRATEGY AND CONSULTATION IN SETTING UP BSF'S FUNDRAISING PROGRAM. ADDITIONALLY, CAMPBELL & COMPANY PROVIDED DESIGN SERVICES TO DEVELOP MATERIALS THAT WOULD BE USED IN FUNDRAISING INITIATIVES. 1 BLOOD SYSTEM INC PO BOX 1867 SCOTTSDALE AZ 85252 860098929 501(C)(3) 5686318 0 N/A N/A OPERATIONAL SUPPORT 1 0 PART I, LINE 2: DOCUMENTATION IS OBTAINED FROM RECIPIENTS THAT DEMONSTRATES COMPLIANCE WITH THE GRANT PARAMETERS. ANY FINDINGS OF NONCOMPLIANCE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT SCHEDULED MEETING. X 0 0 X 1 1 0 0 0 0 0 0 0 JAMES COVERT DIRECTOR 0 113387 0 41946 0 1665116 0 1411 0 22774 0 1844634 0 708764 MARK GIAQUINTO PRESIDENT & CFO 0 279837 0 116676 0 0 0 7793 0 24813 0 429119 0 0 PART I, LINE 1A AIRPLANE AND EXECUTIVE CLUB DUES WERE PAID FOR JAMES COVERT PRIOR TO MARCH 1, 2018. EXECUTIVE CLUB DUES ARE PAID FOR MARK GIAQUINTO. PART I, LINE 3 A COMPENSATION STUDY FOR THE PRESIDENT AND CFO IS PERFORMED BY A THIRD PARTY CONSULTANT EVERY THREE YEARS. THE MOST RECENT STUDY WAS COMPLETED IN 2017. PART I, LINES 4A-B AS PART OF THE BUSINESS TRANSACTION WITH BLOOD SYSTEMS, INC THAT CLOSED ON MARCH 1, 2017, MR. COVERT RECEIVED COMPENSATION PER HIS EMPLOYMENT CONTRACT WHICH INCLUDED A SEVERANCE PAYMENT OF $956,352 AND PAYOUT OF HIS NONQUALIFIED PENSION FUNDS OF $708,764. THE OTHER COMPENSATION AMOUNT SHOWN REFLECTS THE CHANGE DUE TO THE CURTAILMENT AND PAYOUT OF HIS NONQUALIFIED BENEFITS. AS PART OF THE BUSINESS TRANSACTION WITH BLOOD SYSTEMS, INC THAT CLOSED ON MARCH 1, 2017, MR. GIAQUINTO COMPENSATION INCLUDED ONE-TIME PAYMENTS OF A RETENTION PAYMENT AND TRANSACTION BONUS TOTALING $100,000. THE OTHER COMPENSATION AMOUNT SHOWN REFLECTS THE CHANGE DUE TO THE CURTAILMENT OF HIS NONQULAIFIED PLAN BENEFITS ASSOCIATED WITH THE BUSINESS TRANSACTION. FORM 990, PART VI, SECTION A, LINE 7A THE BOARD OF DIRECTORS SHALL CONSIST OF NO FEWER THAN FIVE (5) AND NO MORE THAN NINETEEN (19) INDIVIDUALS. TWO (2) MEMBERS OF THE BOARD OF DIRECTORS (WHO ALSO SERVE ON THE BSI BOARD) WILL BE NOMINATED BY BSI AND APPOINTED BY THE BOARD OF DIRECTORS, TO SERVE AS EX OFFICIO DIRECTORS WITH VOTING RIGHTS. TO THE EXTENT THAT ANY INDIVIDUAL NOMINATED BY BSI IS NOT ACCEPTABLE TO THE BOARD OF DIRECTORS, THE BOARD OF DIRECTORS WILL WORK IN GOOD FAITH WITH BSI'S BOARD TO RESOLVE WHETHER SUCH INDIVIDUAL SHOULD BE ACCEPTED OR ANOTHER INDIVIDUAL SHOULD BE RECOMMENDED. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED WITH THE BOARD OF DIRECTORS IN ADVANCE OF FILING. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR AND EACH OFFICER SHALL MAKE TIMELY DISCLOSURE TO THE PRESIDENT AND THE CHAIRMAN OF THE BOARD OF HIS/HER "PERSONAL INTEREST" IN ANY TRANSACTION OR PROPOSED TRANSACTION KNOWN TO HIM/HER AND TO WHICH THE CORPORATION, ITXM OR BSI, OR THEIR SUBSIDIARIES OR AFFILIATES ARE OR ARE TO BE A PARTY. UPON HIS/HER INITIAL ELECTION TO OFFICE, EACH DIRECTOR SHALL BE FURNISHED A COPY OF THE CONFLICT OF INTEREST POLICY AND ANY RELATED POLICIES ADOPTED BY THE BOARD. THE DIRECTOR OR OFFICER SHALL BE REQUIRED TO EXECUTE A STATEMENT ACKNOWLEDGING: (I) THAT HE/SHE HAS READ AND UNDERSTANDS THE CONTENT THEREOF; (II) THAT HE/SHE HAS BECOME ACQUAINTED WITH THE CHARITABLE AND COMMUNITY SERVICE MISSION OF THE CORPORATION, AND UNDERSTANDS THAT THE CORPORATION MUST ENGAGE PRIMARILY IN, AND DEDICATE ITS RESOURCES EXCLUSIVELY TO, CHARITABLE, SCIENTIFIC AND EDUCATIONAL ACTIVITIES IN PURSUIT OF TAX EXEMPT PURPOSES UNDER THE CODE; AND (III) THAT WHEN ACTING IN THE CAPACITY OF A DIRECTOR OR OFFICER, HE/SHE IS LEGALLY BOUND TO SERVE THE CHARITABLE AND COMMUNITY SERVICE MISSION OF THE CORPORATION AND NOT ANY PERSONAL, PRIVATE OR OTHER INTEREST. THE BOARD SHALL ANNUALLY REQUIRE THAT EACH DIRECTOR AND OFFICER EXECUTE A STATEMENT OF REAFFIRMATION AS TO ALL THE MATTERS SET FORTH ABOVE. FORM 990, PART VI, SECTION B, LINE 15 EFFECTIVE WITH BSF'S CHANGE IN AFFILIATION TO BSI ON MARCH 1, 2017, AON WAS ENGAGED TO PERFORM A COMPENSATION ANALYSIS FOR MR. GIAQUINTO AND HIS NEW POSITION. FORM 990, PART VI, SECTION C, LINE 18 THE ORGANIZATION MAKES THEIR FORM 990 AND FORM 1023 AVAILABLE UPON REQUEST FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES THEIR GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE IN A REASONABLE AMOUNT OF TIME FOLLOWING A WRITTEN REQUEST FOR INSPECTION. INSTITUTE FOR TRANSFUSION MEDICINE PC5 875 GREENTREE RD PITTSBURGH PA 15220 251562714 BLOOD BANK PA 501(C)(3) LINE 12C, III-FI 0 BLOOD SYSTEMS INC PO BOX 1867 SCOTTSDALE AZ 85252 860098929 BLOOD BANK AZ 501(C)(3) LINE 11 0 0 1 1 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 0